The results showed that STAT3 deletion in hematopoietic cells enhanced the ability of DCs to present antigens and activate T‐cells, improved the ability of granulocytes and NKs to eliminate targeting tumor cells, increased T‐cell responses to tumor antigens, and inhibited tumor growth in tumor‐bearing mice.146. Here, STAT3 is linked to neoplasm.